Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$34.5 - $42.19 $33,568 - $41,050
973 Added 2.51%
39,783 $1.68 Million
Q1 2023

May 15, 2023

SELL
$33.32 - $40.98 $197,221 - $242,560
-5,919 Reduced 13.23%
38,810 $1.38 Million
Q4 2022

Feb 14, 2023

SELL
$25.32 - $51.45 $13,799 - $28,040
-545 Reduced 1.2%
44,729 $1.64 Million
Q3 2022

Nov 14, 2022

BUY
$46.5 - $79.14 $202,089 - $343,942
4,346 Added 10.62%
45,274 $2.14 Million
Q2 2022

Aug 15, 2022

SELL
$63.06 - $84.75 $126,687 - $170,262
-2,009 Reduced 4.68%
40,928 $2.93 Million
Q1 2022

May 16, 2022

BUY
$74.15 - $99.36 $287,108 - $384,721
3,872 Added 9.91%
42,937 $3.48 Million
Q4 2021

Feb 14, 2022

SELL
$86.01 - $102.89 $145,012 - $173,472
-1,686 Reduced 4.14%
39,065 $4.01 Million
Q3 2021

Nov 15, 2021

BUY
$84.7 - $96.31 $145,514 - $165,460
1,718 Added 4.4%
40,751 $3.57 Million
Q2 2021

Aug 16, 2021

BUY
$76.44 - $89.57 $96,085 - $112,589
1,257 Added 3.33%
39,033 $3.49 Million
Q1 2021

May 17, 2021

BUY
$67.36 - $80.76 $401,735 - $481,652
5,964 Added 18.75%
37,776 $2.87 Million
Q4 2020

Feb 16, 2021

BUY
$53.08 - $69.86 $1.69 Million - $2.22 Million
31,812 New
31,812 $2.17 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.